Summary : IMCIVREE now available for chronic weight management in adult and pediatric patients 6…
Active Pharmaceutical Ingredients (API)
-
-
Maribavir
Takeda’s LIVTENCITY (Maribavir) Approved by U.S. FDA as the First and Only Treatment of Post-Transplant Cytomegalovirus (CMV), that is Resistant to other Antiviral Drugs.
by adminSYNOPSIS: Takeda announced that U.S. FDA Approved LIVTENCITY (Maribavir) as the First and Only Treatment…
-
PfizerTofacitinib
Pfizer’s XELJANZ® (Tofacitinib) Receives Marketing Authorization in the European Union for the Treatment of Active Ankylosing Spondylitis
by adminAbstract: The European Commission has approved Pfizer`s first-of-its-kind oral Janus kinase (JAK) inhibitor XELJANZ® (Tofacitinib)…
-
Nelarabine
Zydus Cadila receives USFDA Final Approval for Nelarabine Injection a Therapeutically Generic Version of Arranon injection.
by adminKEYPOINTS: Zydus Cadila has received final approval from the US FDA to market Nelarabine injection…
-
Diroximel Fumarate
The European Commission Grants Marketing Authorization for VUMERITY® (Diroximel Fumarate) as Oral Treatment for Relapsing-Remitting Multiple Sclerosis.
by adminSYNOPSIS: VUMERITY is a next-generation oral fumarate treatment for people with relapsing-remitting MS with established…
-
Mepolizumab
GlaxoSmithKline`s Nucala (Mepolizumab) gets European Approval for use in Three Additional Eosinophil-driven Diseases.
by adminKEYPOINTS: GlaxoSmithKline (NYSE:GSK) announces that the European Commission has approved Nucala (Mepolizumab), a monoclonal antibody…
-
Active Pharmaceutical Ingredients (API)Risankizumab
European Commission approves AbbVie’s Skyrizi (Risankizumab) to Treat Adults with Active Psoriatic Arthritis.
by adminKEYPOINTS: AbbVie announces that the European Commission (EC) has approved SKYRIZI (Risankizumab, 150 mg, subcutaneous…
-
Active Pharmaceutical Ingredients (API)Insulin
Biocon Biologics and Viatris launch Interchangeable Biosimilars SEMGLEE and Insulin Glargine Injection in US.
by adminKEYPOINTS: Biocon Biologics and Viatris Inc have launched Semglee (insulin glargine-yfgn) injection, a branded product,…
-
Levodopa and Entacapone
STADA and Bioglan signed an Agreement to Increase Production Capacity to Meet Rising Demand for Parkinson’s Treatment.
by adminKEYWORDS: Bioglan, the Swedish subsidiary of the Spanish pharmaceutical company, and STADA Arzneimittel AG have…
-
Ropeginterferon
FDA Approves Ropeginterferon Alfa-2b-njft (Besremi) Treatment for Rare Blood Disease Polycythemia Vera (PV).
by adminSUMMARY: PharmaEssentia Corporation a global biopharmaceutical innovator based in Taiwan leveraging deep expertise and proven…